Global Ganja Report

Cannabis advocates across the United States and the world bid a grateful farewell to Lester Grinspoon, the Harvard psychiatrist and prolific author who probably did more than any other individual to change the national conversation about marijuana, stressing the need for a more tolerant and enlightened policy.

As the so-called "Boomers" advance in years, they are using cannabis more, a new study reveals. What may have been a symbol of rebellion and the counterculture in their youth, is increasingly seen as medicine to help deal with the challenges of aging.

Growing numbers around the United States and the world are using cannabis to treat a wide spectrum of medical conditions, and legal space is widening for them to do so. So it's a particular irony that hospitals as a rule bar cannabis from their premises. More voices in the medical industry are now grappling with this dilemma.

A ground-breaking study is set to begin in Australia, to determine if cannabis can improve the quality of life of those suffering from dementia. Elderly care facilities are watching closely, hoping cannabis will prove a key to help those they look after lead happier lives, with less medication.

Researchers are exploring the connection between cannabinoids and dopamine in the human brain, and particularly how THC affects our "reward system"—key to such phenomena as motivation, addiction and euphoria. Investigations are revealing both potential for treatments of psychiatric disorders as well as possible risks from heavy use, especially among the young.

Health authorities have named Vitamin E acetate as a likely suspect in the serious illness that has now affected hundreds across the country after vaping either cannabis or tobacco products. In many of the cases illicit-market dab carts appear to be responsible for the severe pulmonary problems that have now resulted in five deaths. But public authorities and the cannabis industry alike caution that research is ongoing.

Among the multiple grim challenges facing humanity at this moment is the specter of "antibiotic apocalypse"—so-called "superbugs" developing resistance to common antibiotics, portending a plague of incurable infections. Research in Australia now reveals anti-bacterial properties in CBD, effective even against the growing ranks of resistant superbugs. Many in the stateside cannabis industry say the development is further evidence that legal barriers to research need to come down—and fast.

The US Surgeon General has launched a new campaign hyping the supposed dangers of cannabis—a further disappointment for activists who held out hope that Trump harbored libertarian instincts and would legalize. All too predictably, the anti-legalization assumptions behind the new campaign are amply refuted by actual research.